(Q71678992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

E Fenouillet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

N Blanes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Benjouad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J C Gluckman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 March 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

419-424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein

20 October 2019

cites work

1 reference

12 December 2020

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects

1 reference

12 December 2020

Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum

1 reference

12 December 2020

The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides

1 reference

12 December 2020

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins

1 reference

12 December 2020

Improved antigenicity of the HIV env protein by cleavage site removal

1 reference

12 December 2020

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

1 reference

12 December 2020

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

1 reference

12 December 2020

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

1 reference

12 December 2020

Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides

1 reference

12 December 2020

Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance

1 reference

12 December 2020

Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children

1 reference

12 December 2020

Neutralization of HIV‐1: a paradox of humoral proportions

1 reference

12 December 2020

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1 reference

12 December 2020

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

1 reference

12 December 2020

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

12 December 2020

Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120

1 reference

12 December 2020

Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker

1 reference

12 December 2020

Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity

1 reference

12 December 2020

Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans

1 reference

12 December 2020

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans

1 reference

12 December 2020

Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection

1 reference

12 December 2020

Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.

1 reference

12 December 2020

The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules

1 reference

12 December 2020

Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.

1 reference

12 December 2020

The role of the V3 loop of gp120 in HIV infection.

1 reference

12 December 2020

V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.

1 reference

12 December 2020

Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons

1 reference

12 December 2020

Diversity of the V3 region of HIV in Paris, France

1 reference

12 December 2020

Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB05567.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7533680%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference